Back to Search
Start Over
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
- Source :
- Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019), Arthritis Research & Therapy
- Publication Year :
- 2019
- Publisher :
- BMC, 2019.
-
Abstract
- Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
lcsh:Diseases of the musculoskeletal system
Placebo
Golimumab
Arthritis, Rheumatoid
03 medical and health sciences
0302 clinical medicine
Double-Blind Method
Internal medicine
medicine
Humans
Rheumatoid arthritis
Infusions, Intravenous
Aged
030203 arthritis & rheumatology
Dose-Response Relationship, Drug
business.industry
Incidence (epidemiology)
Age Factors
Antibodies, Monoclonal
Middle Aged
medicine.disease
Rheumatology
030104 developmental biology
Methotrexate
Treatment Outcome
Cellulitis
Antirheumatic Agents
Anti-tumor necrosis factor
Disease Progression
Acute pancreatitis
Drug Therapy, Combination
Female
lcsh:RC925-935
business
Geriatric
medicine.drug
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 14786362
- Volume :
- 21
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Arthritis Research & Therapy
- Accession number :
- edsair.doi.dedup.....a29a1cc5efe7d9c298041a58c00e2e66
- Full Text :
- https://doi.org/10.1186/s13075-019-1968-x